Back to Treatments

Treatment

Ibrutinib

1
Conditions
172
Trials
8,000
Participants
42%
Average Safety

Condition Evidence

Chronic lymphoid leukemia

172 trials · 8,000 participants

86% effectiveness · 42% safety
Ibrutinib | DFDA